Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ (1997) J Exp Med 185: 1705-10 A critical, invariant chain-independent role for H2-M in antigen presentation. Swier K, Brown DR, Bird JJ, Martin WD, Van Kaer L, Reiner SL (1998) J Immunol 160: 540-4 Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection. Roberts LJ, Baldwin TM, Speed TP, Handman E, Foote SJ (1999) Eur J Immunol 29: 3047-50 Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania. Rana T, Misra S, Mittal MK, Farrow AL, Wilson KT, Linton MF, Fazio S, Willis IM, Chaudhuri G (2011) J Biol Chem 286: 6614-26 Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Elso CM, Roberts LJ, Smyth GK, Thomson RJ, Baldwin TM, Foote SJ, Handman E (2004) Genes Immun 5: 93-100 Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine. Serezani CH, Franco AR, Wajc M, Umada Yokoyama-Yasunaka JK, Wunderlich G, Borges MM, Uliana SR (2002) Vaccine 20: 3755-63 A type II ribonuclease H from Leishmania mitochondria: an enzyme essential for the growth of the parasite. Misra S, Bennett J, Friew YN, Abdulghani J, Irvin-Wilson CV, Tripathi MK, Williams S, Chaudhuri M, Chaudhuri G (2005) Mol Biochem Parasitol 143: 135-45 A new standard for the assessment of disease progression in murine cutaneous leishmaniasis. Roberts LJ, Foote SJ, Handman E (2000) Parasite Immunol 22: 231-7 Reinfection in American cutaneous leishmaniasis: evaluation of clinical outcomes in the hamster model. Osorio Y, Gonzalez SJ, Gama VL, Travi BL (1998) Mem Inst Oswaldo Cruz 93: 353-6
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.